NZ MP Liz Gunn has called for a formal inquiry on COVID vax death.
"Not just any inquiry," she says, "a full-blown criminal investigation leaving no stone unturned. New Zealand is a crime scene. Computers of anyone associated with this COVID response rollout in any capacity, mobile phones, communications, bank accounts, archives, and a whole host of other targeted information must be seized.
“We have OIA evidence, Official Information Act evidence, that “the government knew every side effect before one single jab was given in New Zealand.” The sources for her claim can be found among the many links in the story below.
Gunn declared that the New Zealand government had access to Pfizer’s post-marketing data, which revealed 1,223 deaths and page upon page of adverse events, before the government commenced its mass “vaccination” campaign on March 10, 2021.
"We saw in the data that there are many clusters of deaths. People who attended the same jab site and were jabbed one after the other at consecutive times on the same day. We saw their jab date. We saw their date of death. Let me give you just one of many examples.
"On one day, 30 people were jabbed on the same day at the same location. All are now deceased, and their deaths are in close temporal time proximity to each other. That's 30. That's all players in a rugby match on the field suddenly dead. You see, statistically, the numbers of deaths we saw cannot be attributed to natural causes, given same site and same date of vaccination. It would be what they say statistically highly unlikely.
The FDA has rejected its strongest safety warning for Covid mRNA vaccines despite acknowledging that children were killed by the products.
This news surfaced during a televised Bloomberg interview with FDA Commissioner Marty Makary, who said the agency has “no plans” to apply its strongest safety warning to Covid mRNA vaccines.
In that interview, Makary confirmed that the FDA’s own safety and epidemiology centre had formally recommended a boxed warning — a step reserved, under FDA rules, for drugs with “special problems, particularly ones that may lead to death or serious injury.”